Chronic kidney disease progression results in elevated serum levels of FGF23, which are associated with left ventricular hypertrophy, a major contributor to cardiovascular disease (Gutiérrez et al., 2009). This evidence concerns the gene FGF23 and left ventricular hypertrophy.